Longboard Pharmaceuticals Price Prediction

LBPHDelisted Stock  USD 59.98  0.00  0.00%   
The relative strength index (RSI) of Longboard Pharmaceuticals' share price is above 70 as of 21st of December 2024. This indicates that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling Longboard, making its price go up or down.

Oversold Vs Overbought

77

 
Oversold
 
Overbought
The successful prediction of Longboard Pharmaceuticals' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Longboard Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Using Longboard Pharmaceuticals hype-based prediction, you can estimate the value of Longboard Pharmaceuticals from the perspective of Longboard Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Longboard Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Longboard because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Longboard Pharmaceuticals after-hype prediction price

    
  USD 59.88  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
Intrinsic
Valuation
LowRealHigh
36.4244.0865.98
Details
Naive
Forecast
LowNextHigh
57.1364.7872.44
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
59.9659.9859.99
Details

Longboard Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Longboard Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Longboard Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Longboard Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Longboard Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Longboard Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Longboard Pharmaceuticals' historical news coverage. Longboard Pharmaceuticals' after-hype downside and upside margins for the prediction period are 52.22 and 67.54, respectively. We have considered Longboard Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
59.98
59.88
After-hype Price
67.54
Upside
Longboard Pharmaceuticals is not too volatile at this time. Analysis and calculation of next after-hype price of Longboard Pharmaceuticals is based on 3 months time horizon.

Longboard Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Longboard Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Longboard Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Longboard Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  1.39 
7.66
  0.10 
  0.08 
10 Events / Month
13 Events / Month
In about 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
59.98
59.88
0.17 
10,943  
Notes

Longboard Pharmaceuticals Hype Timeline

Longboard Pharmaceuticals is now traded for 59.98. The entity has historical hype elasticity of -0.1, and average elasticity to hype of competition of -0.08. Longboard is projected to decline in value after the next headline, with the price expected to drop to 59.88. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.17%, whereas the daily expected return is now at 1.39%. The volatility of related hype on Longboard Pharmaceuticals is about 13078.05%, with the expected price after the next announcement by competition of 59.90. About 99.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 2.25. Longboard Pharmaceuticals had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in about 10 days.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Longboard Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Longboard Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Longboard Pharmaceuticals' future price movements. Getting to know how Longboard Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Longboard Pharmaceuticals may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
MOLNMolecular Partners AG(0.22)7 per month 4.50  0.04  9.38 (7.22) 52.92 
MNOVMediciNova 0.08 9 per month 3.49  0.08  9.95 (6.44) 61.30 
ANEBAnebulo Pharmaceuticals 0.03 6 per month 0.00 (0.09) 7.59 (11.48) 76.00 
CSBRChampions Oncology 0.27 8 per month 3.60  0.15  7.97 (5.05) 23.94 
CYTCyteir Therapeutics 0.09 2 per month 2.57  0.1  10.00 (5.26) 36.14 
HOWLWerewolf Therapeutics(0.14)6 per month 0.00 (0.05) 8.54 (8.75) 49.02 
EWTXEdgewise Therapeutics(0.12)8 per month 3.28  0.03  6.44 (5.54) 26.07 
DBTXDecibel Therapeutics 0.01 1 per month 4.12  0.07  7.85 (7.45) 26.09 
CELCCelcuity LLC(0.73)7 per month 0.00 (0.1) 4.20 (5.83) 16.97 
CCCCC4 Therapeutics 0.04 7 per month 0.00 (0.13) 9.28 (8.28) 24.60 
ASMBAssembly Biosciences 0.50 7 per month 0.00 (0.04) 8.88 (6.83) 21.34 
NXTCNextCure(0.05)5 per month 0.00 (0.14) 5.43 (7.75) 24.13 
NUVBNuvation Bio 0.03 10 per month 0.00 (0.02) 9.48 (8.36) 21.30 
GRPHGraphite Bio(0.03)1 per month 0.00 (0.04) 4.79 (4.73) 14.40 
TILInstil Bio(0.59)7 per month 0.00 (0.19) 12.77 (9.99) 30.36 
SNSESensei Biotherapeutics 0.01 3 per month 7.52  0.04  11.11 (13.21) 110.76 
MACKMerrimack Pharmaceuticals 0.00 0 per month 0.00 (0.07) 1.89 (1.74) 7.02 
GLUEMonte Rosa Therapeutics(0.83)10 per month 4.59  0.05  8.40 (8.46) 103.72 
DSGNDesign Therapeutics 0.39 6 per month 5.91  0.04  8.54 (8.80) 33.11 
IKNAIkena Oncology(0.01)2 per month 0.00 (0.12) 1.80 (2.35) 8.46 
STOKStoke Therapeutics 0.04 8 per month 0.00 (0.09) 5.57 (5.30) 21.35 

Longboard Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Longboard price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Longboard using various technical indicators. When you analyze Longboard charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Longboard Pharmaceuticals Predictive Indicators

The successful prediction of Longboard Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Longboard Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Longboard Pharmaceuticals based on analysis of Longboard Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Longboard Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Longboard Pharmaceuticals's related companies.

Story Coverage note for Longboard Pharmaceuticals

The number of cover stories for Longboard Pharmaceuticals depends on current market conditions and Longboard Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Longboard Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Longboard Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Longboard Pharmaceuticals Short Properties

Longboard Pharmaceuticals' future price predictability will typically decrease when Longboard Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Longboard Pharmaceuticals often depends not only on the future outlook of the potential Longboard Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Longboard Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding22.7 M
Cash And Short Term Investments48.5 M
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Consideration for investing in Longboard Stock

If you are still planning to invest in Longboard Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Longboard Pharmaceuticals' history and understand the potential risks before investing.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance